The Director-General of the Pasteur Institute of Algeria, Dr. Fawzi Derrar, announced today, Sunday in Algiers, that 15 million doses of anti-Coronavirus vaccine will be received during next October.
The same official confirmed that a contract was concluded with one of the laboratories producing the vaccine and that 15 million doses will be received during the month of October.
With the receipt of this quantity, which will be added to the previous quantities, Algeria will be able – as he stressed- to vaccinate 70 percent of the population, or 20 million people, in line with the goal set by public authorities.
Meanwhile, Derrar indicated that 8 million people have benefited from the vaccine so far, 3 million of whom have received the second dose and 5 million have received the first dose.
As for the side effects of the vaccines acquired by Algeria, Dr. Derrar said that “slight symptoms that differ from one person to another without any harm have been recorded,” stressing that even the countries which produce these vaccines have proven, through the clinical trials they conducted, that they “did not record serious side effects.”
